Abstract:The conventional formulation of luliconazole (LCZ) faces challenges such as poor solubility and limited skin retention upon application. Therefore, the focus of this research was to develop and characterize mesoporous silica nanoparticles (MSN) that can effectively deliver luliconazole for the treatment of cutaneous candidiasis fungal infection. The MSNs were optimized by central composite design and synthesized using the sol−gel method. Factors such as stirring time and surfactant ratio were varied to investigate their impact on particle size and Polydispersity index (PDI). Subsequently, the MSN surface was functionalized with both amine (positively charged) and phosphonate groups (negatively charged) using 3-aminopropyltriethoxysilane (APTES) and 3trihydroxysilyl propyl methylphosphonate (THMP). The efficacy of the optimized luliconazole−loaded MSNs was evaluated through various comparative studies, including in-vitro and in-vivo antifungal assessments, ex-vivo permeation and skin retention experiments, acute dermal irritation tests, and histopathological analysis. These evaluations were compared with the pure drug and a commercially available formulation. The optimized MSNs exhibited high porosity and spherical particle sizes ranging from 300 to 400 nm. They demonstrated excellent physical and chemical stability, indicating compatibility between the drug and the MSN structure. The successful loading of luliconazole into the nanopores of the MSNs was confirmed through Brunauer Emmett Teller (BET) analysis. The luliconazole−loaded MSN (LCZ−MSN) gel exhibited a controlled release profile, sustaining drug release for up to 24 h. The solubility of the drug was 12 times higher compared to the free form, and the MSNs enhanced skin retention by six−fold compared to the pure drug. In an in-vivo cutaneous candidiasis rat model, the enhanced efficacy of the MSNs was evident, highlighting the potential of this innovative approach for controlled release and solubility enhancement of poorly soluble drugs, with no observed skin irritation. Overall, this research showcases the potential of mesoporous silica nanoparticles as a promising approach for controlled delivery and improved solubility of poorly soluble drugs like luliconazole, thereby addressing the challenges associated with conventional formulations and offering a novel strategy for treating cutaneous candidiasis fungal infection.

Fuzzy Systems and Fuzzy Control Robust Fault Tolerant Fuzzy control for Nonlinear Systems with Actuator Failures

Synergistic Anti-MRSA Activity of Cationic Nanostructured Lipid Carriers in Combination With Oxacillin for Cutaneous Application

Management of Hypoglossal Schwannomas: Single Institutional Experience of 14 Cases

Investigating topical delivery of erythromycin laden into lipid nanocarrier for enhancing the anti-bacterial activity

Luteolin-loaded nanostructured lipid carriers using propolis wax and safflower oil: formulation, optimization, and characterization for antibacterial and antioxidant improvement

[Effectiveness of chemotherapy in patients with pulmonary tuberculosis in Uzbekistan].

Susceptibilities of Clinical and Laboratory Isolates of Blastomyces dermatitidis to Ketoconazole, Itraconazole, and Fluconazole

Synergistic approach for acne vulgaris treatment using glycerosomes loaded with lincomycin and lauric acid: Formulation, in silico, in vitro, LC-MS/MS skin deposition assay and in vivo evaluation

Antibacterial, Antibiofilm, and Antiviral Farnesol-Containing Nanoparticles Prevent Staphylococcus aureus from Drug Resistance Development

Fucoidan-loaded, neutrophil membrane-coated nanoparticles facilitate MRSA-accompanied wound healing

Formulation development and characterization of luliconazole loaded−mesoporous silica nanoparticles (MCM−48) as topical hydrogel for the treatment of cutaneous candidiasis

Novel Formulation of Fusidic Acid Incorporated into a Myrrh-Oil-Based Nanoemulgel for the Enhancement of Skin Bacterial Infection Treatment

Lipid nanoparticles based on natural matrices with activity against multidrug resistant bacterial species

Integration of terpesomes loaded Levocetrizine dihydrochloride gel as a repurposed cure for Methicillin-Resistant Staphylococcus aureus (MRSA)-Induced skin infection; D-optimal optimization, ex-vivo, in-silico, and in-vivo studies

Development of Liposomal Systems of Finasteride for Topical Applications: Design, Characterization, and In Vitro Evaluation

Formulation Development and In Vitro/In Vivo Characterization of Methotrexate-Loaded Nanoemulsion Gel Formulations for Enhanced Topical Delivery

Formulation and optimization of surfactant-modified chitosan nanoparticles loaded with cefdinir for novel topical drug delivery: Elevating wound healing efficacy with enhanced antibacterial properties

Physiological and antimicrobial properties of a novel nanoemulsion formulation containing mixed surfactant and essential oils: Optimization modeling by response surface methodology

Exploring the possible targeting strategies of liposomes against methicillin-resistant Staphylococcus aureus (MRSA)

Pharmaco-Technical Evaluation of Statistically Formulated and Optimized Dual Drug-Loaded Silica Nanoparticles for Improved Antifungal Efficacy and Wound Healing

Design and Characterisation of Curcumin-Loaded Nanostructured Lipid Carriers for Safe and Efficient Topical Drug Delivery in The Treatment of Pressure Ulcer